Brief: Kissei Pharmaceutical Co Ltd Announces Withdrawal Of Application For Marketing Approval For Rovatirelin(KPS-0373) For Treatment Of Spinocerebellar Degeneration In Japan
19/07/2023 07:01
Kissei Pharmaceutical Co Ltd 4547.T :
* KISSEI PHARMACEUTICAL CO LTD: ANNOUNCES WITHDRAWAL OF
APPLICATION FOR MARKETING APPROVAL FOR ROVATIRELIN(KPS-0373) FOR
TREATMENT OF SPINOCEREBELLAR DEGENERATION IN JAPAN
Source text for Eikon: ID:nTSss7fe91
Further company coverage: 4547.T